Densely adherent growth mode, rather than extracellular polymer substance matrix build-up ability, contributes to high resistance of Staphylococcus epidermidis biofilms to antibiotics

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 7, 2010, Pages 1405-1411

  Qu, Yue ^a   Daley, Andrew J ^b   Istivan, Taghrid S ^a   Rouch, Duncan A ^a   Deighton, Margaret A ^a  

^a RMIT UNIVERSITY   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Antibiotic resistance; Coagulase negative staphylococci; Monolayer biofilms; Multilayer biofilms; Persister cells

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; OXACILLIN; POLYMER; RIFAMPICIN; VANCOMYCIN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BIOPOLYMER; MODE PROTEIN, BACTERIA; TRANSCRIPTION FACTOR;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIABILITY; BIOFILM; CONTROLLED STUDY; DENSITY; ERADICATION THERAPY; GENE MUTATION; GENETIC VARIABILITY; MINIMUM INHIBITORY CONCENTRATION; MONOLAYER CULTURE; NONHUMAN; STAPHYLOCOCCUS EPIDERMIDIS; BACTERIUM ADHERENCE; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIAL VIABILITY; PHYSIOLOGY;

ANTI-BACTERIAL AGENTS; BACTERIAL ADHESION; BACTERIAL PROTEINS; BIOFILMS; BIOPOLYMERS; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; STAPHYLOCOCCUS EPIDERMIDIS; TRANSCRIPTION FACTORS;

EID: 77954178660     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq119     Document Type: Article

References (38)

1. Christensen GD, Simpson WA, Bisno AL et al. Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect Immun 1982; 37: 318-26.
2. von Eiff C, Peters G, Heilmann C. Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect Dis 2002; 2: 677-85.
3. Vuong C, Otto M. Staphylococcus epidermidis infections. Microbes Infect 2002; 4: 481-9.
4. Otto M. Virulence factors of the coagulase-negative staphylococci. Front Biosci 2004; 9: 841-63.
5. Lewis K. Riddle of biofilm resistance. Antimicrob Agents Chemother 2001; 45: 999-1007.
6. Anderson GG, O'Toole GA. Innate and induced resistance mechanisms of bacterial biofilms. Curr Top Microbiol Immunol 2008; 322: 85-105.
7. Stewart PS. Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbiol 2002; 292: 107-13.
8. Christensen GD, Simpson WA, Younger JJ et al. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 1985; 22: 996-1006.
9. Deighton MA, Capstick J, Domalewski E et al. Methods for studying biofilms produced by Staphylococcus epidermidis. Methods Enzymol 2001; 336: 177-95.
10. Karatan E, Watnick P. Signals, regulatory networks, and materials that build and break bacterial biofilms. Microbiol Mol Biol Rev 2009; 73: 310-47.
11. Presterl E, Hajdu S, Lassnigg AM et al. Effects of azithromycin in combination with vancomycin, daptomycin, fosfomycin, tigecycline, and ceftriaxone on Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother 2009; 53: 3205-10.
12. Spoering AL, Lewis K. Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J Bacteriol 2001; 183: 6746-51.
13. Ceri H, Olson M, Morck D et al. The MBEC Assay System: multiple equivalent biofilms for antibiotic and biocide susceptibility testing. Methods Enzymol 2001; 337: 377-85.
14. Aaron SD, Ferris W, Ramotar K et al. Single and combination antibiotic susceptibilities of planktonic, adherent, and biofilm-grown Pseudomonas aeruginosa isolates cultured from sputa of adults with cystic fibrosis. J Clin Microbiol 2002; 40: 4172-9.
15. Zhang L, Mah TF. Involvement of a novel efflux system in biofilm-specific resistance to antibiotics. J Bacteriol 2008; 190: 4447-52.
16. Lewis K. Persister cells and the riddle of biofilm survival. Biochemistry 2005; 70: 267-74.
17. Lewis K. Persister cells, dormancy and infectious disease. Nat Rev Microbiol 2007; 5: 48-56.
18. Higashi JM, Wang IW, Shlaes DM et al. Adhesion of Staphylococcus epidermidis and transposon mutant strains to hydrophobic polyethylene. J Biomed Mater Res 1998; 39: 341-50.
19. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically-Seventh Edition: Approved Standard M7-A7. NCCLS, Wayne, PA, USA, 2004.
20. Gualtieri M, Bastide L, Villain-Guillot P et al. In vitro activity of a new antibacterial rhodanine derivative against Staphylococcus epidermidis biofilms. J Antimicrob Chemother 2006; 58: 778-83.
21. Dales L, Ferris W, Vandemheen K et al. Combination antibiotic susceptibility of biofilm-grown Burkholderia cepacia and Pseudomonas aeruginosa isolated from patients with pulmonary exacerbations of cystic fibrosis. Eur J Clin Microbiol Infect Dis 2009; 28: 1275-9.
22. Mah TF, O'Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 2001; 9:34-9.
23. Wright DH, Gunderson BW, Hovde LB et al. Comparative pharmacodynamics of three newer fluoroquinolones versus six strains of staphylococci in an in vitro model under aerobic and anaerobic conditions. Antimicrob Agents Chemother 2002; 46: 1561-3.
24. Zabinski RA, Larsson AJ, Walker KJ et al. Elimination of quinolone antibiotic carryover through use of antibiotic-removal beads. Antimicrob Agents Chemother 1993; 37: 1377-9.
25. Tomihama T, Nishi Y, Arai K. Biofilm formation and resistance to bactericides of Pseudomonas syringae pv. theae. J Gen Plant Pathol 2007; 73: 193-6.
26. Labthavikul P, Petersen PJ, Bradford PA. In vitro activity of tigecycline against Staphylococcus epidermidis growing in an adherent-cell biofilm model. Antimicrob Agents Chemother 2003; 47: 3967-9.
27. Edmiston CE Jr, Goheen MP, Seabrook GR et al. Impact of selective antimicrobial agents on staphylococcal adherence to biomedical devices. Am J Surg 2006; 192: 344-54.
28. Qu Y, Istivan TS, Daley AJ et al. Comparison of various antimicrobial agents as catheter lock solutions: preference for ethanol in eradication of coagulase-negative staphylococcal biofilms. J Med Microbiol 2009; 58: 442-50.
29. Otto M. Staphylococcus epidermidis-the 'accidental' pathogen. Nat Rev Microbiol 2009; 7: 555-67.
30. Zheng Z, Stewart PS. Penetration of rifampin through Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother 2002; 46: 900-3.
31. Dunne WM Jr, Mason EO Jr, Kaplan SL. Diffusion of rifampin and vancomycin through a Staphylococcus epidermidis biofilm. Antimicrob Agents Chemother 1993; 37: 2522-6.
32. Al-Dhaheri RS, Douglas LJ. Absence of amphotericin B-tolerant persister cells in biofilms of some Candida species. Antimicrob Agents Chemother 2008; 52: 1884-7.
33. Singh R, Ray P, Das A et al. Role of persisters and small-colony variants in antibiotic resistance of planktonic and biofilm-associated Staphylococcus aureus:anin vitro study. J Med Microbiol 2009; 58: 1067-73.
34. Keren I, Shah D, Spoering A et al. Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J Bacteriol 2004; 186: 8172-80.
35. Keren I, Kaldalu N, Spoering A et al. Persister cells and tolerance to antimicrobials. FEMS Microbiol Lett 2004; 230:13-8.
36. LaFleur MD, Kumamoto CA, Lewis K. Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob Agents Chemother 2006; 50: 3839-46.
37. Vandecasteele SJ, Peetermans WE, Merckx R et al. Expression of biofilm-associated genes in Staphylococcus epidermidis during in vitro and in vivo foreign body infections. J Infect Dis 2003; 188: 730-7.
38. Yao Y, Sturdevant DE, Otto M. Genomewide analysis of gene expression in Staphylococcus epidermidis biofilms: insights into the pathophysiology of S. epidermidis biofilms and the role of phenol-soluble modulins in formation of biofilms. J Infect Dis 2005; 191: 289-98.